Bismuth citrate (BioDeep_00000815419)

   


代谢物信息卡片


Bismuth(3+) citrate

化学式: C6H5BiO7 (397.983916)
中文名称: 柠檬酸铋
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Bi+3]
InChI: /q

描述信息

C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
D005765 - Gastrointestinal Agents > D000863 - Antacids
D000890 - Anti-Infective Agents

同义名列表

2 个代谢物同义名

Bismuth(3+) citrate; Bismuth citrate



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Yao Chen, Qingyi Liu, Fulian Hu, Jizheng Ma. Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases. MicrobiologyOpen. 2020 11; 9(11):e1120. doi: 10.1002/mbo3.1120. [PMID: 33026166]
  • Bernardo Guevara, Asha Gupta Cogdill. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies. Digestive diseases and sciences. 2020 07; 65(7):1917-1931. doi: 10.1007/s10620-020-06193-7. [PMID: 32170476]
  • Estelle Guiard, Bénédicte Lelievre, Magali Rouyer, Frank Zerbib, Bertrand Diquet, Francis Mégraud, François Tison, Emmanuelle Bignon, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore, Patrick Blin. Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study. Drug safety. 2019 08; 42(8):993-1003. doi: 10.1007/s40264-019-00821-6. [PMID: 31069703]
  • Dong-Min Yi, Tao-Tao Yang, Shuai-Heng Chao, Ya-Xin Li, Ying-Lei Zhou, Hai-Hui Zhang, Ling Lan, Yu-Wei Zhang, Xue-Mei Wang, Yan-Rui Zhang, Jian Li, Song-Ze Ding. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study. Medicine. 2019 Feb; 98(6):e14408. doi: 10.1097/md.0000000000014408. [PMID: 30732192]
  • Runming Wang, Tsz-Pui Lai, Peng Gao, Hongmin Zhang, Pak-Leung Ho, Patrick Chiu-Yat Woo, Guixing Ma, Richard Yi-Tsun Kao, Hongyan Li, Hongzhe Sun. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors. Nature communications. 2018 01; 9(1):439. doi: 10.1038/s41467-018-02828-6. [PMID: 29382822]
  • Nezihat Rana Disel, Ayça Açikalin, Ahmet Sebe, Yüksel Gokel. Utilization of plasmapheresis in the management of bismuth intoxication with acute renal failure. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2017 May; 28(3):629-632. doi: 10.4103/1319-2442.206438. [PMID: 28540904]
  • Ferdane Sapmaz, Ismail H Kalkan, Incilay Suslu, Hüseyin Demirci, Pinar Atasoy, Sefa Guliter. Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus. Journal of digestive diseases. 2015 Sep; 16(9):531-6. doi: 10.1111/1751-2980.12272. [PMID: 26147605]
  • Asghar Rahmani, Ghobad Abangah, Atefeh Moradkhani, Mohammad Reza Hafezi Ahmadi, Khairollah Asadollahi. Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H. pylori infection. Journal of clinical pharmacology. 2015 Aug; 55(8):842-7. doi: 10.1002/jcph.508. [PMID: 25854786]
  • Christos Kokkinos, Mamas Prodromidis, Anastasios Economou, Panagiota Petrou, Sotirios Kakabakos. Disposable integrated bismuth citrate-modified screen-printed immunosensor for ultrasensitive quantum dot-based electrochemical assay of C-reactive protein in human serum. Analytica chimica acta. 2015 Jul; 886(?):29-36. doi: 10.1016/j.aca.2015.05.035. [PMID: 26320633]
  • Enzo Ierardi, Antonio Giangaspero, Giuseppe Losurdo, Floriana Giorgio, Annacinzia Amoruso, Vincenzo De Francesco, Alfredo Di Leo, Mariabeatrice Principi. Quadruple rescue therapy after first and second line failure for Helicobacter pylori treatment: comparison between two tetracycline-based regimens. Journal of gastrointestinal and liver diseases : JGLD. 2014 Dec; 23(4):367-70. doi: 10.15403/jgld.2014.1121.234.qrth. [PMID: 25531993]
  • Seyed Mousal Reza Hosseini, Farzane Sharifipoor, Fateme Nazemian, Hossein Ghanei, Hamid Reza Zivarifar, Tahereh Fakharian. Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?. Acta medica Iranica. 2014; 52(4):271-4. doi: NULL. [PMID: 24901856]
  • Shah Hussain, Stefan A Schönbichler, Yüksel Güzel, Harald Sonderegger, Gudrun Abel, Matthias Rainer, Christian W Huck, Günther K Bonn. Solid-phase extraction of galloyl- and caffeoylquinic acids from natural sources (Galphimia glauca and Arnicae flos) using pure zirconium silicate and bismuth citrate powders as sorbents inside micro spin columns. Journal of pharmaceutical and biomedical analysis. 2013 Oct; 84(?):148-58. doi: 10.1016/j.jpba.2013.05.029. [PMID: 23831490]
  • Ligang Hu, Tianfan Cheng, Bin He, Lu Li, Yuchuan Wang, Yau-Tsz Lai, Guibin Jiang, Hongzhe Sun. Identification of metal-associated proteins in cells by using continuous-flow gel electrophoresis and inductively coupled plasma mass spectrometry. Angewandte Chemie (International ed. in English). 2013 Apr; 52(18):4916-20. doi: 10.1002/anie.201300794. [PMID: 23553936]
  • NULL. Bismuth + metronidazole + tetracycline. Why risk adding bismuth?. Prescrire international. 2013 Apr; 22(137):89-92. doi: NULL. [PMID: 23662315]
  • Wei Xia, Xin Zhang, Jiajia Wang, Caihong Sun, Lijie Wu. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. The British journal of nutrition. 2012 Jul; 108(2):357-62. doi: 10.1017/s0007114511005666. [PMID: 22004585]
  • Jiang Lin, Wei-Wen Huang. A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine. World journal of gastroenterology. 2009 Oct; 15(37):4715-9. doi: 10.3748/wjg.15.4715. [PMID: 19787835]
  • Jens Boertz, Louise Michele Hartmann, Margareta Sulkowski, Joerg Hippler, Frank Mosel, Roland Arturo Diaz-Bone, Klaus Michalke, Albert Wolfgang Rettenmeier, Alfred Vitalis Hirner. Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate. Drug metabolism and disposition: the biological fate of chemicals. 2009 Feb; 37(2):352-8. doi: 10.1124/dmd.107.020313. [PMID: 18981168]
  • Lun-Hua Chen, He-Sheng Luo. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. World journal of gastroenterology. 2007 Oct; 13(40):5380-3. doi: 10.3748/wjg.v13.i40.5380. [PMID: 17879411]
  • F Geyikoglu, H Turkez, A Aslan. The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity. Toxicology and industrial health. 2007 Sep; 23(8):487-92. doi: 10.1177/0748233708089044. [PMID: 18669170]
  • Ruiguang Ge, Xuesong Sun, Qing Gu, Rory M Watt, Julian A Tanner, Benjamin Chun Yu Wong, Harry Huaxiang Xia, Jian-Dong Huang, Qing-Yu He, Hongzhe Sun. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry. 2007 Aug; 12(6):831-42. doi: 10.1007/s00775-007-0237-7. [PMID: 17503094]
  • Alexander A Nijevitch, Valery U Sataev, Elsa N Akhmadeyeva, Alexander G Arsamastsev. Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. Helicobacter. 2007 Apr; 12(2):132-5. doi: 10.1111/j.1523-5378.2007.00482.x. [PMID: 17309749]
  • Nurcan Cengiz, Yasemin Uslu, Faysal Gök, Ali Anarat. Acute renal failure after overdose of colloidal bismuth subcitrate. Pediatric nephrology (Berlin, Germany). 2005 Sep; 20(9):1355-8. doi: 10.1007/s00467-005-1993-7. [PMID: 15947979]
  • James C Hutson. Effects of bismuth citrate on the viability and function of Leydig cells and testicular macrophages. Journal of applied toxicology : JAT. 2005 May; 25(3):234-8. doi: 10.1002/jat.1060. [PMID: 15856528]
  • Li Zhang, Shu-tian Zhang, Zhong-lin Yu, Ying Shao. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate]. Zhonghua nei ke za zhi. 2005 Apr; 44(4):272-5. doi: NULL. [PMID: 15924641]
  • Hasan Türkez, Fatime Geyikoğlu, M Sait Keleş. Biochemical response to colloidal bismuth subcitrate: dose-time effect. Biological trace element research. 2005; 105(1-3):151-8. doi: 10.1385/bter:105:1-3:151. [PMID: 16034160]
  • Kubilay Cinar, Irfan Soykan, Ali Ozden. The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2004 Sep; 15(3):159-63. doi: NULL. [PMID: 15492914]
  • Jean Spénard, Christian Aumais, Julie Massicotte, Claude Tremblay, Marc Lefebvre. Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline. Journal of clinical pharmacology. 2004 Jun; 44(6):640-5. doi: 10.1177/0091270004265643. [PMID: 15145972]
  • L Cariani, L Thomas, J Brito, J R del Castillo. Bismuth citrate in the quantification of inorganic phosphate and its utility in the determination of membrane-bound phosphatases. Analytical biochemistry. 2004 Jan; 324(1):79-83. doi: 10.1016/j.ab.2003.09.008. [PMID: 14654048]
  • Agnete Larsen, Nargot Martiny, Meredin Stoltenberg, Gorm Danscher, Jørgen Rungby. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Pharmacology & toxicology. 2003 Aug; 93(2):82-90. doi: NULL. [PMID: 12899670]
  • Yu-cai Zhang, Ding-hua Tang, Liang Xu. [Bismuth subcitrate caused acute renal failure in a child]. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2003 Feb; 41(2):122. doi: NULL. [PMID: 14759317]
  • R K Goel, K Sairam, M Dora Babu, I A Tavares, A Raman. In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2003; 10(6-7):523-7. doi: 10.1078/094471103322331494. [PMID: 13678238]
  • Berend T Leussink, J Fred Nagelkerke, Bob van de Water, Anja Slikkerveer, Gijsbert B van der Voet, Anu Srinivasan, Jan A Bruijn, Frederik A de Wolff, Emile de Heer. Pathways of proximal tubular cell death in bismuth nephrotoxicity. Toxicology and applied pharmacology. 2002 Apr; 180(2):100-9. doi: 10.1006/taap.2002.9379. [PMID: 11969377]
  • Metin Sarikaya, Alper Sevinc, Ramazan Ulu, Fehmi Ates, Fahri Ari. Bismuth subcitrate nephrotoxicity. A reversible cause of acute oliguric renal failure. Nephron. 2002 Apr; 90(4):501-2. doi: 10.1159/000054741. [PMID: 11961412]
  • Petr Hruz, Michael Mayr, Roland Löw, Jürgen Drewe, Gerold Huber. Fanconi's syndrome, acute renal failure, and tonsil ulcerations after colloidal bismuth subcitrate intoxication. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002 Mar; 39(3):E18. doi: 10.1053/ajkd.2002.31429. [PMID: 11877598]
  • G N Sokolova, T M Tsaregorodtseva, M M Zotina. [Changes in local humoral immunity during stomach ulcer healing with laser and drug therapy]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology. 2002; ?(2):58-61, 103. doi: NULL. [PMID: 12046389]
  • D Newton, R J Talbot, N D Priest. Human biokinetics of injected bismuth-207. Human & experimental toxicology. 2001 Dec; 20(12):601-9. doi: 10.1191/096032701718890586. [PMID: 11936573]
  • I Işlek, S Uysal, F Gök, R Dündaröz, S Küçüködük. Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate. Pediatric nephrology (Berlin, Germany). 2001 Jun; 16(6):510-4. doi: 10.1007/s004670100584. [PMID: 11420918]
  • R H Phillips, M W Whitehead, L A Doig, C E Sieniawska, H T Delves, R P Thompson, J J Powell. Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?. Helicobacter. 2001 Jun; 6(2):151-6. doi: 10.1046/j.1523-5378.2001.00022.x. [PMID: 11422471]
  • B T Leussink, A Slikkerveer, M R Engelbrecht, G B van der Voet, E J Nouwen, E de Heer, M E de Broe, F A de Wolff, J A Bruijn. Bismuth overdosing-induced reversible nephropathy in rats. Archives of toxicology. 2001 Feb; 74(12):745-54. doi: 10.1007/s002040000190. [PMID: 11305776]
  • B T Leussink, A Slikkerveer, W J Krauwinkel, G B van der Voet, E de Heer, F A de Wolff, J A Bruijn. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats. Archives of toxicology. 2000 Sep; 74(7):349-55. doi: 10.1007/s002040000150. [PMID: 11043489]
  • R H Phillips, M W Whitehead, S Lacey, M Champion, R P Thompson, J J Powell. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Helicobacter. 2000 Sep; 5(3):176-82. doi: 10.1046/j.1523-5378.2000.00028.x. [PMID: 10971684]
  • H Sun, H Li, I Harvey, P J Sadler. Interactions of bismuth complexes with metallothionein(II). The Journal of biological chemistry. 1999 Oct; 274(41):29094-101. doi: 10.1074/jbc.274.41.29094. [PMID: 10506163]
  • O Hundal, M Bergseth, B Gharehnia, K J Andersen, A Berstad. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers. Hepato-gastroenterology. 1999 Sep; 46(29):2882-6. doi: NULL. [PMID: 10576366]
  • C A Fallone, V G Loo, A N Barkun. Utility of serology in determining Helicobacter pylori eradication after therapy. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 1998 Mar; 12(2):117-24. doi: 10.1155/1998/303628. [PMID: 9559206]
  • J Canena, J Reis, A S Pinto, A M Santos, J Leitão, T Pinheiro, M G Quina. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate. The Journal of pharmacy and pharmacology. 1998 Mar; 50(3):279-83. doi: 10.1111/j.2042-7158.1998.tb06861.x. [PMID: 9600719]
  • A el-Nujumi, C Williams, J E Ardill, K Oien, K E McColl. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment. Gut. 1998 Feb; 42(2):159-65. doi: 10.1136/gut.42.2.159. [PMID: 9536937]
  • A Slikkerveer, L A Noach, G N Tytgat, G B Van der Voet, F A De Wolff. Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid. The Analyst. 1998 Jan; 123(1):91-2. doi: 10.1039/a704945e. [PMID: 9581027]
  • D Bagchi, O R Carryl, M X Tran, M Bagchi, P J Vuchetich, R L Krohn, S D Ray, S Mitra, S J Stohs. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts. Digestive diseases and sciences. 1997 Sep; 42(9):1890-900. doi: 10.1023/a:1018811210175. [PMID: 9331152]
  • J P Gisbert, D Boixeda, C Martín De Argila, I Alvarez Baleriola, V Abraira, A García Plaza. Unhealed duodenal ulcers despite Helicobacter pylori eradication. Scandinavian journal of gastroenterology. 1997 Jul; 32(7):643-50. doi: 10.3109/00365529708996512. [PMID: 9246702]
  • W Baffone, F Belbusti, E Barbieri, A Pianetti, F Bruscolini, M T Fabi, L Salvaggio, A Albano. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori. Journal of chemotherapy (Florence, Italy). 1997 Jun; 9(3):208-12. doi: 10.1179/joc.1997.9.3.208. [PMID: 9210004]
  • G Treiber, S Walker, U Klotz. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication. Arzneimittel-Forschung. 1997 Jan; 47(1):47-50. doi: NULL. [PMID: 9037444]
  • N Rao, P W Brown, P Yerino, J Chang, K K Hwang. Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate. Biopharmaceutics & drug disposition. 1997 Jan; 18(1):1-8. doi: 10.1002/(sici)1099-081x(199701)18:1<1::aid-bdd996>3.0.co;2-0. [PMID: 9008264]
  • I Akpolat, H Kahraman, N Arik, T Akpolat, B Kandemir, K Cengiz. Acute renal failure due to overdose of colloidal bismuth. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1996 Sep; 11(9):1890-1. doi: NULL. [PMID: 8918651]
  • J P Gisbert, D Boixeda, T Vila, L de Rafael, C Redondo, R Cantón, C Martín de Argila. Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori. Scandinavian journal of gastroenterology. 1996 Feb; 31(2):103-10. doi: 10.3109/00365529609031972. [PMID: 8658030]
  • H H Tsai, A D Dwarakanath, C A Hart, J D Milton, J M Rhodes. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut. 1995 Apr; 36(4):570-6. doi: 10.1136/gut.36.4.570. [PMID: 7737566]
  • T Rokkas, G Papatheodorou, A Karameris, A Mavrogeorgis, N Kalogeropoulos, N Giannikos. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Digestive diseases and sciences. 1995 Mar; 40(3):615-21. doi: 10.1007/bf02064380. [PMID: 7895555]
  • F Iwańczak, H Rajska, B Iwańczak, H Górecka. Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study. Roczniki Akademii Medycznej w Bialymstoku (1995). 1995; 40(3):685-91. doi: NULL. [PMID: 8775327]
  • T Mach. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs]. Folia medica Cracoviensia. 1995; 36(1-4):53-75. doi: NULL. [PMID: 8834668]
  • V Wewer, K M Christiansen, L P Andersen, F W Henriksen, J P Hansen, M Tvede, P A Krasilnikoff. Helicobacter pylori infection in children with recurrent abdominal pain. Acta paediatrica (Oslo, Norway : 1992). 1994 Dec; 83(12):1276-81. doi: 10.1111/j.1651-2227.1994.tb13015.x. [PMID: 7734870]
  • T S Chen, S H Tsay, F Y Chang, S D Lee. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study. The American journal of gastroenterology. 1994 Sep; 89(9):1511-4. doi: NULL. [PMID: 8079929]
  • G Treiber, S Walker, U Klotz. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate. Clinical pharmacology and therapeutics. 1994 May; 55(5):486-91. doi: 10.1038/clpt.1994.61. [PMID: 8181192]
  • M Ashorn, T Ruuska, R Karikoski, A Miettinen, M Mäki. Helicobacter pylori gastritis in dyspeptic children. A long-term follow-up after treatment with colloidal bismuth subcitrate and tinidazole. Scandinavian journal of gastroenterology. 1994 Mar; 29(3):203-8. doi: 10.3109/00365529409090464. [PMID: 8209177]
  • C U Nwokolo, J D Fitzpatrick, R Paul, R Dyal, B J Smits, D E Loft. Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate. Alimentary pharmacology & therapeutics. 1994 Feb; 8(1):45-53. doi: 10.1111/j.1365-2036.1994.tb00159.x. [PMID: 8186346]
  • L F Lacey, N M Frazer, O N Keene, J T Smith. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB). European journal of clinical pharmacology. 1994; 47(2):177-80. doi: 10.1007/bf00194969. [PMID: 7859806]
  • S Zommer-Urbańska, E Bulska, R Pawlaczyk, M Kukliński. Determination of bismuth in rabbit blood serum and tissues after administration of pharmaceuticals containing Bi2O3. Acta poloniae pharmaceutica. 1994; 51(1):7-10. doi: NULL. [PMID: 7976437]
  • W D Paar, F J Wieres, D Bösche, A Glasmacher, H J Dengler. [Pharmacokinetics of colloidal bismuth subcitrate. Solution versus tablet]. Arzneimittel-Forschung. 1993 Nov; 43(11):1189-92. doi: NULL. [PMID: 8292062]
  • H Vanhoe, J Versieck, L Vanballenberghe, R Dams. Bismuth in human serum: reference interval and concentrations after intake of a therapeutic dose of colloidal bismuth subcitrate. Clinica chimica acta; international journal of clinical chemistry. 1993 Oct; 219(1-2):79-91. doi: 10.1016/0009-8981(93)90199-e. [PMID: 8306466]
  • H P Wirth, J Wüst, R Flury, G Zala, C Casanova, P Bertschinger, R Ammann, R Münch. [A trial of modified triple therapy for the eradication of H. pylori in recurrent duodenal ulcer]. Schweizerische medizinische Wochenschrift. 1993 Sep; 123(35):1645-9. doi: NULL. [PMID: 8211015]
  • G M Sobala, C J Schorah, S Shires, D A Lynch, B Gallacher, M F Dixon, A T Axon. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut. 1993 Aug; 34(8):1038-41. doi: 10.1136/gut.34.8.1038. [PMID: 8174949]
  • E el-Omar, I Penman, C A Dorrian, J E Ardill, K E McColl. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 1993 Aug; 34(8):1060-5. doi: 10.1136/gut.34.8.1060. [PMID: 8174954]
  • T J Borody, P Andrews, E Jankiewicz, N Ferch, M Carroll. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. The American journal of gastroenterology. 1993 Aug; 88(8):1266-8. doi: NULL. [PMID: 8338096]
  • S F Moss, J Calam. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut. 1993 Jul; 34(7):888-92. doi: 10.1136/gut.34.7.888. [PMID: 8344574]
  • A G Fraser, W M Lam, Y W Luk, J Sercombe, A M Sawyerr, M Hudson, I M Samloff, R E Pounder. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut. 1993 Mar; 34(3):338-42. doi: 10.1136/gut.34.3.338. [PMID: 8472980]
  • F Huwez, A Pall, D Lyons, M J Stewart. Acute renal failure after overdose of colloidal bismuth subcitrate. Lancet (London, England). 1992 Nov; 340(8830):1298. doi: 10.1016/0140-6736(92)93005-8. [PMID: 1359362]
  • D Vaira, J Holton, C Ainley, M Falzon, J Osborn, L D'Anna, A Romanos, K Chandrakumaran, I McNeil. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. The Italian journal of gastroenterology. 1992 Sep; 24(7):400-4. doi: NULL. [PMID: 1392023]
  • J Weil, G D Bell, K Powell. Disposition of bismuth and renal function. Alimentary pharmacology & therapeutics. 1992 Jun; 6(3):395-7. doi: NULL. [PMID: 1600056]
  • K Beardshall, S Moss, J Gill, S Levi, P Ghosh, R J Playford, J Calam. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut. 1992 May; 33(5):601-3. doi: 10.1136/gut.33.5.601. [PMID: 1612474]
  • S Madaus, E Schulte-Frohlinde, C Scherer, A Kämmereit, V Schusdziarra, M Classen. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate. Alimentary pharmacology & therapeutics. 1992 Apr; 6(2):241-9. doi: 10.1111/j.1365-2036.1992.tb00267.x. [PMID: 1288519]
  • B Dresow, R Fischer, E E Gabbe, J Wendel, H C Heinrich. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease. Scandinavian journal of gastroenterology. 1992 Apr; 27(4):333-6. doi: 10.3109/00365529209000083. [PMID: 1589712]
  • S F Moss, R J Playford, K Ayesu, S K Li, J Calam. pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori. Digestion. 1992; 52(3-4):173-8. doi: 10.1159/000200950. [PMID: 1459351]
  • C U Nwokolo, J F Lewin, M Hudson, R E Pounder. Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology. 1992 Jan; 102(1):163-7. doi: 10.1016/0016-5085(92)91796-7. [PMID: 1727749]
  • G Treiber, U Gladziwa, T H Ittel, S Walker, F Schweinsberg, U Klotz. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function. Alimentary pharmacology & therapeutics. 1991 Oct; 5(5):491-502. doi: 10.1111/j.1365-2036.1991.tb00518.x. [PMID: 1793780]
  • C U Nwokolo, E J Prewett, A M Sawyerr, M Hudson, R E Pounder. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds. Gastroenterology. 1991 Oct; 101(4):889-94. doi: 10.1016/0016-5085(91)90712-t. [PMID: 1889712]
  • E J Prewett, J T Smith, C U Nwokolo, M Hudson, A M Sawyerr, R E Pounder. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Alimentary pharmacology & therapeutics. 1991 Jun; 5(3):283-90. doi: 10.1111/j.1365-2036.1991.tb00029.x. [PMID: 1888827]
  • K E McColl, G M Fullarton, R Chittajalu, A M el Nujumi, A M MacDonald, S W Dahill, T E Hilditch. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scandinavian journal of gastroenterology. 1991 Mar; 26(3):339-46. doi: 10.3109/00365529109025052. [PMID: 1853158]
  • J A Armstrong, M Cooper, C S Goodwin, J Robinson, S H Wee, M Burton, V Burke. Influence of soluble haemagglutinins on adherence of Helicobacter pylori to HEp-2 cells. Journal of medical microbiology. 1991 Mar; 34(3):181-7. doi: 10.1099/00222615-34-3-181. [PMID: 2010909]
  • L Z Benet. Safety and pharmacokinetics: colloidal bismuth subcitrate. Scandinavian journal of gastroenterology. Supplement. 1991; 185(?):29-35. doi: 10.3109/00365529109093217. [PMID: 1957122]
  • C De Giacomo, R Fiocca, L Villani, L Lisato, G Licardi, N Diegoli, A Donadini, G Maggiore. Helicobacter pylori infection and chronic gastritis: clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. Journal of pediatric gastroenterology and nutrition. 1990 Oct; 11(3):310-6. doi: . [PMID: 2246711]
  • C U Nwokolo, R E Pounder. D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate. British journal of clinical pharmacology. 1990 Oct; 30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x. [PMID: 2291879]
  • M T Wells, S L Gaffin, B C Wessels, J G Brock-Utne, J P Jordaan, J van den Ende. Anti-LPS antibodies reduce endotoxemia in whole body 60Co irradiated primates: a preliminary report. Aviation, space, and environmental medicine. 1990 Sep; 61(9):802-6. doi: NULL. [PMID: 2241744]
  • A J McLean, S Islam, J R Lambert. Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate. Gut. 1990 Sep; 31(9):1086. doi: 10.1136/gut.31.9.1086. [PMID: 2210458]
  • E G Taylor, P Klenerman. Acute renal failure after colloidal bismuth subcitrate overdose. Lancet (London, England). 1990 Mar; 335(8690):670-1. doi: 10.1016/0140-6736(90)90464-g. [PMID: 1969052]
  • R J Playford, C H Matthews, M J Campbell, H T Delves, K K Hla, H J Hodgson, J Calam. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure. Gut. 1990 Mar; 31(3):359-60. doi: 10.1136/gut.31.3.359. [PMID: 2323603]
  • R León-Barúa, R Tello, M C Morante, M Alvarez, R H Gilman, W M Spira. In vitro and in vivo effects of three bismuth compounds on fermentation by colonic bacteria. Reviews of infectious diseases. 1990 Jan; 12 Suppl 1(?):S24-9. doi: 10.1093/clinids/12.supplement_1.s24. [PMID: 2305175]
  • B L Slomiany, C Kasinathan, A Slomiany. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol). The American journal of gastroenterology. 1989 Oct; 84(10):1273-7. doi: ". [PMID: 2801678]
  • M Hudson, N A Mowat. Reversible toxicity in poisoning with colloidal bismuth subcitrate. BMJ (Clinical research ed.). 1989 Jul; 299(6692):159. doi: 10.1136/bmj.299.6692.159. [PMID: 2504358]
  • M Lazzaroni, M Petrillo, G Bianchi Porro. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer. The British journal of clinical practice. 1989 Apr; 43(4):151-5. doi: NULL. [PMID: 2590626]
  • C U Nwokolo, C J Gavey, J T Smith, R E Pounder. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Alimentary pharmacology & therapeutics. 1989 Feb; 3(1):29-39. doi: 10.1111/j.1365-2036.1989.tb00188.x. [PMID: 2491456]
  • C J Gavey, M L Szeto, C U Nwokolo, J Sercombe, R E Pounder. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Alimentary pharmacology & therapeutics. 1989 Feb; 3(1):21-8. doi: 10.1111/j.1365-2036.1989.tb00187.x. [PMID: 2491455]